Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial

Abstract

The two-compound scalp formulation was superior to calcipotriol scalp solution in improving QoL in patients with scalp psoriasis.

Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice

“…A positive influence on the QoL of the scalp formulation was demonstrated. Our results confirm two former studies in adults with scalp psoriasis . However, these studies used other instruments to measure quality of life, namely, Skindex‐16 (16‐item Short Form Health Survey) and the Scalp Life Quality Index (derived from the Dermatology Life Quality Index) .…”

Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review

“…Ortonne et al. showed a statistically significant treatment difference in Skindex‐16 total score in favor of the two‐compound scalp gel formulation over calcipotriol scalp solution at week 2, week 4 ( P < 0.001) and week 8 ( P < 0.008) 37 . The group differences in the SF‐36v2 score were not significant.…”

The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life

“…Examples of this use include studies of therapies for psoriasis 17,18 , acne vulgaris 19 , and atopic dermatitis 20 .…”